Rocha advises a broad, multidisciplinary client base across the healthcare value chain, from pharmaceutical, chemical pharma, and biotech firms to medtech, digital health, CROs, hospitals, and agri biotech ventures, translating strategic objectives into legal, regulatory, and transactional architectures that unlock growth with measured risk. Her work bridges the lab and the market, aligning operational design, intellectual property stewardship, and regulatory governance to enable cycles of innovation, scalability, and monetization

With a focus on value creation and risk mitigation, Rocha leads the structuring and negotiation of corporate transactions, asset deals, joint ventures, commercial alliances, and investment platforms, as well as licensing, R&D partnerships, and spin offs. Her practice spans the formation of regulated purpose entities, robust compliance frameworks, and complex restructurings, integrating regulatory diligence, healthcare product and service liability, and reputational safeguards, all guided by performance metrics and transparent governance

At the intersection of business, science, and regulation, Rocha works shoulder to shoulder with C suite executives, investors, developers, and clinicians to orchestrate the full cycle of development, approval, and market access. She aligns regulatory strategy, tax efficiency, privacy and data protection, quality systems, and patient safety. Her experience includes AI in healthcare, SaMD, interoperability and data exchange, IoMT, wearables, biofabrication, and digital care models, translating technological advances into regulatory impact and transactional value, with clear pathways to registration, reimbursement, and sustainable expansion